Correlation Between Vera Therapeutics and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and Organon Co, you can compare the effects of market volatilities on Vera Therapeutics and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Organon.

Diversification Opportunities for Vera Therapeutics and Organon

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vera and Organon is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Organon go up and down completely randomly.

Pair Corralation between Vera Therapeutics and Organon

Given the investment horizon of 90 days Vera Therapeutics is expected to generate 2.11 times more return on investment than Organon. However, Vera Therapeutics is 2.11 times more volatile than Organon Co. It trades about 0.11 of its potential returns per unit of risk. Organon Co is currently generating about -0.01 per unit of risk. If you would invest  900.00  in Vera Therapeutics on August 27, 2024 and sell it today you would earn a total of  3,931  from holding Vera Therapeutics or generate 436.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vera Therapeutics  vs.  Organon Co

 Performance 
       Timeline  
Vera Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vera Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Vera Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Vera Therapeutics and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vera Therapeutics and Organon

The main advantage of trading using opposite Vera Therapeutics and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Vera Therapeutics and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm